Page last updated: 2024-09-04

moxifloxacin and quinazolines

moxifloxacin has been researched along with quinazolines in 3 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(quinazolines)
Trials
(quinazolines)
Recent Studies (post-2010) (quinazolines)
3,1575521,69019,2352,4178,835

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)quinazolines (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.027

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, P; Borer, J1
Beaufils, P; Cabanis, MJ; Extramiana, F; Leenhardt, A; Maison-Blanche, P; Ortemann-Renon, C1
Takai, N; Tanaka, Y1

Trials

1 trial(s) available for moxifloxacin and quinazolines

ArticleYear
Clinical assessment of drug-induced QT prolongation in association with heart rate changes.
    Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Predictive Value of Tests; Quinazolines; Quinolines; Reproducibility of Results; Treatment Outcome

2005

Other Studies

2 other study(ies) available for moxifloxacin and quinazolines

ArticleYear
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003.
    Circulation, 2003, Jun-17, Volume: 107, Issue:23

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adolescent; Adult; Advisory Committees; Anti-Infective Agents; Aza Compounds; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Approval; Electrocardiography; Fluoroquinolones; Humans; Imidazoles; Impotence, Vasculogenic; Male; Middle Aged; Moxifloxacin; Phosphoric Diester Hydrolases; Piperazines; Prostatic Hyperplasia; Quinazolines; Quinolines; Risk Assessment; Sulfones; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride

2003
Imaging of drug and metabolite distribution by MS: case studies.
    Bioanalysis, 2015, Volume: 7, Issue:20

    Topics: Animals; Autoradiography; Dogs; Fluoroquinolones; Lapatinib; Liver; Lung; Mice; Moxifloxacin; Pharmaceutical Preparations; Quinazolines; Rabbits; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terfenadine; Tissue Distribution; Whole Body Imaging

2015